InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Vickers Philip J., 董事. Officer active across 2 companies, notably Revance Therapeutics, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €34k. History available since 5 May 2021. The latest transaction was disclosed on 4 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Vickers Philip J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
6,059 股0Common StockSEC:0001479290-22-000064:0
4,800 股@ US$8.35100.0% 占其流量Common StockSEC:0001127602-21-021729:0
标准退出：2021年10月5日 (T+90)
4,013 股0Common StockSEC:0001479290-21-000116:0
3 条申报中的 3 条
About Vickers Philip J.
Philip J. Vickers is a Board Member at Revance Therapeutics, Inc. and AVROBIO, Inc. In this role, he contributes to the governance of these companies, bringing his expertise to the board. Revance Therapeutics is a biopharmaceutical company, while AVROBIO focuses on gene therapy. Mr. Vickers's experience in these sectors is valuable for guiding strategic decisions.
